The Eng lab currently identifies and characterises genes that are thought to cause susceptibility to inherited cancer syndromes, determining their role in random carcinogenesis and analyses their molecular epidemiology as they relate to clinical applications.[7] This framework allowed her team to elucidate the function of PTEN mutations in Cowden Syndrome, an inherited condition that increases the risk of certain cancers in humans.[2][8][9]